Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 11, 2025

The Native Brand, P&G Studios und dentsu Entertainment präsentieren Amerikas erste gemeinsam produzierte Langspiel-„Mikro-Soap“ für das Zeitalter vertikaler Videos, produziert von Pixie USA, mit dem Titel „The Golden Pear Affair“

View original at globenewswire.com
The Native Brand, P&G Studios und dentsu Entertainment präsentieren Amerikas erste gemeinsam produzierte Langspiel-„Mikro-Soap“ für das Zeitalter vertikaler Videos, produziert von Pixie USA, mit dem Titel „The Golden Pear Affair“ LOS ANGELES, Dec…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Microdramas are expected to generate $11 billion USD in worldwide revenue by 2025, with the U.S. emerging as the largest market outside China

    80% confidence
  • dentsu has always stood for innovation, finding new ways to reach audiences and connecting brands through fandom; microdramas are conquering the world and dentsu is expanding its position in this rapidly growing format

    80% confidence
  • Native is excited to bring the brand into entertainment world with micro-soap series inspired by Global Flavors collection, seeking innovative ways to reach customers where they are

    80% confidence
  • P&G Studios is committed to enhancing consumer interaction with brands through innovation, combining classic brand storytelling with evolving mobile entertainment landscape

    80% confidence
  • Microdramas are the natural evolution of the soap opera format introduced by P&G decades ago, and Pixie USA is proud to lead this tradition into a new era with Native

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com
The Native Brand, P&G Studios und dentsu Entertainment präsentieren Amerikas erste gemeinsam produzierte Langspiel-„Mikro-Soap“ für das Zeitalter vertikaler Videos, produziert von Pixie USA, mit dem Titel „The Golden Pear Affair“ — Source | Via News | Finance Via News